Medisprudence exists because of one specific professional experience that no competitor has — and a commitment to following the analysis rather than a side. Plaintiff teams, defense firms, TPAs, and carriers all engage the same physician analyst under conflict-screened, separate engagements.
Dr. Kasturi is an MBBS physician with a background that spans clinical medicine and US payer-side utilization-review work under InterQual and MCG. He founded Medisprudence to bring the documentation-threshold discipline developed through payer-side review into the litigation support market — where that perspective is directly useful to attorneys and exactly what no competitor currently offers.
MBBS physician with clinical experience across internal medicine and multi-system pathology. Foundation for causation, mechanism, and treatment-record analysis.
Payer-side US claim review at scale. Applied InterQual and MCG criteria across 3,000+ cases. This is the background no competitor has.
LLB (in progress). Analysis is framed around litigation decisions — not patient treatment decisions. Work product is designed for attorney use.
Understanding of payer utilization management operations, claims evaluation, and how defense medical theories are constructed, from first-hand criteria application.
India-based operation disclosed before records are accepted. Cross-border processing disclosed before PHI is transmitted. AI use disclosed at the component level on every deliverable.
Medisprudence provides medical consulting under attorney direction. No legal advice, no patient care, no independent expert testimony, no court appearances unless separately contracted.
On the payer side, physician reviewers evaluate thousands of claims against specific criteria — InterQual levels of care, MCG surgical appropriateness guidelines, and payer-specific medical necessity thresholds. The question in every review is the same question a defense IME physician asks: does this record document the clinical necessity for the treatment claimed?
After 3,000+ of those reviews, the documentation patterns that make a claim defensible and the gaps that make it vulnerable become precise and specific knowledge — not clinical opinion. You know exactly which absence of conservative care documentation will trigger a surgery denial. You know which imaging findings without EMG cross-reference leave a radiculopathy claim exposed. You know which treatment gap lengths require clinical explanation and which ones do not.
Medisprudence does not use confidential, proprietary, or plan-specific information from any current or prior employer. All analysis is based on publicly available clinical guidelines and general utilization review methodology.
Bilateral service: Medisprudence serves both plaintiff and defense under conflict-screened, separate engagements. How we handle both sides →